BIOSPECIFICS TECHNOLOGIES CORP
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|---|
| Revenue | $38.2M | $33.0M | $27.4M | $26.3M | $22.8M | $14.0M |
| Operating income | $28.3M | $23.4M | $5.0M | $17.0M | $14.4M | $7.0M |
| Net income | $24.5M | $20.1M | $3.3M | $11.4M | $9.6M | $4.6M |
| Total assets | $126.7M | $100.1M | $75.0M | $64.7M | $45.7M | $31.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $124.5M | $97.6M | $67.5M | $56.3M | $44.8M | $30.3M |
| EPS (diluted) | $3.33 | $2.73 | $0.46 | $1.56 | $1.32 | $0.66 |
| Shares out. | 7.3M | 7.2M | 7.2M | 7.0M | 6.7M | 6.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- 74.1%
- Net margin
- 64.1%
- Return on equity
- 19.7%
- Return on assets
- 19.3%
- Return on capital (ROCE)
- 22.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $17.08
- Revenue growth (YoY)
- 15.9%
- Net income growth (YoY)
- 22.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Accruals / assets
- 1.7%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 18, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2008
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2006
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2005
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2005
- NT 10-Qmissed a reporting deadline ↗May 16, 2005
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventDec 2, 2020
- Results of operationsNov 9, 2020
- Entered a material agreement · Modified shareholder rights · Director / officer change · Other material eventOct 19, 2020
- Regulation FD disclosureSep 14, 2020
- Entered a material agreementAug 31, 2020
- Regulation FD disclosureAug 11, 2020
- Results of operationsAug 10, 2020
- Regulation FD disclosureJul 20, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 16, 2021
- SC 13G/AFeb 10, 2021
- 15-12BDec 22, 2020
- 4FORM 4 SUBMISSIONDec 8, 2020
- SC 13D/ADec 4, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- 4FORM 4 SUBMISSIONDec 2, 2020
- SC 13D/ADec 2, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.